Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24930674)


Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.

Togashi Y, Arao T, Kato H, Matsumoto K, Terashima M, Hayashi H, de Velasco MA, Fujita Y, Kimura H, Yasuda T, Shiozaki H, Nishio K.

Oncotarget. 2014 May 30;5(10):2962-73.


Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.

Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY.

Gastroenterology. 2014 Jun;146(7):1701-13.e9. doi: 10.1053/j.gastro.2014.02.029. Epub 2014 Feb 21.


ORAOV1 is amplified in oral squamous cell carcinoma.

Xavier FC, Rodini CO, Paiva KB, Destro MF, Severino P, Moyses RA; Head and Neck Genome Project GENCAPO, Tajara EH, Nunes FD.

J Oral Pathol Med. 2012 Jan;41(1):54-60. doi: 10.1111/j.1600-0714.2011.01053.x. Epub 2011 May 28.


ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.

Li M, Cui X, Shen Y, Dong H, Liang W, Chen Y, Hu J, Li S, Kong J, Li H, Zhao J, Li F.

Hum Pathol. 2015 May;46(5):707-15. doi: 10.1016/j.humpath.2015.01.009. Epub 2015 Feb 4.


Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.

Tian X, Ma P, Sui CG, Meng FD, Li Y, Fu LY, Jiang T, Wang Y, Jiang YH.

FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.


CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.

Lee KW, Sung CO, Kim JH, Kang M, Yoo HY, Kim HH, Um SH, Kim SH.

Int J Cancer. 2015 Jan 15;136(2):310-21. doi: 10.1002/ijc.29006. Epub 2014 Jun 26.


Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.

Jiang L, Zeng X, Yang H, Wang Z, Shen J, Bai J, Zhang Y, Gao F, Zhou M, Chen Q.

Int J Cancer. 2008 Oct 15;123(8):1779-86. doi: 10.1002/ijc.23734.


Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.

Ito T, Shimada Y, Kan T, David S, Cheng Y, Mori Y, Agarwal R, Paun B, Jin Z, Olaru A, Hamilton JP, Yang J, Abraham JM, Meltzer SJ, Sato F.

Cancer Res. 2008 May 1;68(9):3214-24. doi: 10.1158/0008-5472.CAN-07-3043.


Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.

Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W.

Br J Cancer. 2013 Oct 15;109(8):2266-78. doi: 10.1038/bjc.2013.548. Epub 2013 Sep 10.


Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.

Kwon J, Lee TS, Lee HW, Kang MC, Yoon HJ, Kim JH, Park JH.

Int J Oncol. 2013 Nov;43(5):1523-30. doi: 10.3892/ijo.2013.2097. Epub 2013 Sep 13.


NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.

Yang Q, Ou C, Liu M, Xiao W, Wen C, Sun F.

Carcinogenesis. 2014 Jul;35(7):1643-51. doi: 10.1093/carcin/bgu084. Epub 2014 Apr 7.


Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.

Fatima S, Chui CH, Tang WK, Hui KS, Au HW, Li WY, Wong MM, Cheung F, Tsao SW, Lam KY, Beh PS, Wong J, Law S, Srivastava G, Ho KP, Chan AS, Tang JC.

Int J Mol Med. 2006 Jan;17(1):159-70.


Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.

Li W, Zheng J, Deng J, You Y, Wu H, Li N, Lu J, Zhou Y.

Gastroenterology. 2014 Jun;146(7):1714-26.e5. doi: 10.1053/j.gastro.2014.03.002. Epub 2014 Mar 12.


RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.

Jiang XR, Yu XY, Fan JH, Guo L, Zhu C, Jiang W, Lu SH.

Cancer Lett. 2014 Oct 10;353(1):78-86. doi: 10.1016/j.canlet.2014.07.013. Epub 2014 Jul 18.


Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.

Lin C, Song L, Liu A, Gong H, Lin X, Wu J, Li M, Li J.

Oncogene. 2015 Jan 15;34(3):384-93. doi: 10.1038/onc.2013.559. Epub 2014 Jan 13.


Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.

Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, Fu L, Hu L, Guan XY.

Oncogene. 2009 Aug 6;28(31):2821-8. doi: 10.1038/onc.2009.137. Epub 2009 Jun 15.


Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Ma S, Bao JY, Kwan PS, Chan YP, Tong CM, Fu L, Zhang N, Tong AH, Qin YR, Tsao SW, Chan KW, Lok S, Guan XY.

Gastroenterology. 2012 Sep;143(3):675-86.e1-12. doi: 10.1053/j.gastro.2012.06.007. Epub 2012 Jun 13.


Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.

Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y, Liu Z.

Clin Cancer Res. 2006 Mar 1;12(5):1639-46.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk